ASCO GI 2023 Phase II NRG-GI002 Clinical Trial: Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

ecancer

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

ASCO GI 2023 Phase II NRG-GI002 Clinical Trial: Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

By ecancer FEATURING Thomas George

43 views

February 13, 2023

Comments 0

Login

Login

Join VuMedi

ecancer

ASCO GI 2023 Phase II NRG-GI002 Clinical Trial: Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

ASCO GI 2023 CheckMate 648 Study: Survival Benefit of Nivo + Chemo &…

ASCO GI 2023 Phase 3 OPERA Trial: Nonoperative Modality Treatments o…

ASCO GI 2023 Phase II NRG-GI002 Clinical Trial: Total Neoadjuvant Th…